ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1. Dr. Kristin Yarema receives significant equity awards as new CEO. 2. Inducement awards include stock options for 436,080 shares and RSUs for 153,505 shares. 3. Awards are tied to performance and long-term service requirements. 4. ImageneBio is advancing its lead asset IMG-007 in clinical trials. 5. Company focuses on immunological and inflammatory disease treatments.